Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
IMCD N.V. is a global leader in the distribution and formulation of specialty chemicals and ingredients. Founded in 1995 in Rotterdam, Netherlands, by a group of companies under the leadership of Piet van der Slikke, it emerged from Internatio-Müller as a dedicated player in specialty chemicals distribution, emphasizing technical expertise, international reach, and minimal bureaucracy. The company bridges manufacturers and end-users across diverse industries including coatings, personal care, pharmaceuticals, food, agrochemicals, plastics, and industrial solutions, offering tailored formulations, market intelligence, and logistical support through over 80 technical centers worldwide. IMCD N.V. has expanded aggressively via strategic acquisitions—such as Interorgana in 1996, entry into Brazil in 2013, and 12 deals in 2024—now operating in more than 60 countries with 5,126 employees and generating €4.73 billion in 2024 revenue, diversified geographically: EMEA (40.7%), Asia-Pacific (27.1%), North America (21%), Latin America (9.8%), and Netherlands (1.4%). Listed on Euronext Amsterdam since its 2013 IPO, it upholds a two-tier board structure under Dutch law, prioritizing sustainability via its 2030 Agenda, digital transformation with AI tools, and strategic pillars like commercial excellence and ESG leadership, earning Platinum EcoVadis status in 2025. This positions IMCD N.V. as a vital link in global supply chains, fostering innovation and efficiency.
Operating margin is thin at 7.77%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue growth slowed to 1.1%, essentially flat. Margins also contracted 1.2pp. This is a business that needs a catalyst.
Net debt of €1.48B represents 4.9x FCF, leverage limits flexibility.
Profitability & Returns
Revenue (TTM)
€4.78B
▲ +1.1% YoY
Net Income (TTM)
€217M
▼ -21.8% YoY
Op. Margin
7.77%
▼ -1.2pp YoY
ROIC
7.23%
▼ -1.8pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
€302M
▲ +19.5% YoY
Op. Cash Flow (TTM)
€315M
▲ +18.1% YoY
Net Debt
€1.48B
Cash & Equiv.
€236M
3Y CAGR: +1.3%
3Y CAGR: +2.8%
Continue Research